Stevanato Group S.p.A. (STVN) is a publicly traded Healthcare sector company. As of May 21, 2026, STVN trades at $17.75 with a market cap of $4.86B and a P/E ratio of 0.00. STVN moved +2.42% today. Year to date, STVN is -15.68%; over the trailing twelve months it is -27.01%. Its 52-week range spans $12.89 to $28.00. Analyst consensus is strong buy with an average price target of $26.07. Rallies surfaces STVN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Hedge funds tracked by Rallies that own STVN include Centerbook Partners and Soros Fund. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Stevanato Group S.p.A..
| Metric | Value |
|---|---|
| Price | $17.75 |
| Market Cap | $4.86B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.05% |
| 52-Week High | $28.00 |
| 52-Week Low | $12.89 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
5 analysts cover STVN: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $26.07.